ImmunoPrecise Antibodies Ltd. — Form D
ImmunoPrecise Antibodies Ltd. of Victoria, A1, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-30. The offering totals $3.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-07-30
- Form: D
- Accession: 0000912282-24-000550
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.0M
- Remaining: $1.0M
- Investors: 1
- Date of first sale: 2024-07-16
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-520087
Issuer
- Name: ImmunoPrecise Antibodies Ltd.
- CIK: 0001715925
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 3204 - 4464 Markham Street, Victoria, A1, V8Z 7X8
- Phone: 6048060626
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Jennifer Bath | Director | Victoria, A1 |
| Chris Buyse | Director | Victoria, A1 |
| Mitch Levine | Director | Gilbert, AZ |
| Barry Springer | Director | Victoria, A1 |
| Dirk Witters | Director | Victoria, A1 |
| Jennifer Bath | Executive Officer | Victoria, A1 |
| Ilse Roodnik | Executive Officer | Victoria, A1 |
| Kristin Taylor | Executive Officer | Cambridge, MA |
| Greg Smith | Director | San Diego, CA |
| Natasha Tsai | Executive Officer | Vancouver, A1 |
| Thomas D'Orazio | Director | Madison, WI |
| Thomas D'Orazio | Executive Officer | Madison, WI |
| ROBERT BURKE | Director | DUBLIN, L2 |
| James Kuo | Director | Hialeah, FL |
| Robert Beecroft | Director | Victoria, A1 |
| Robert Beecroft | Executive Officer | Victoria, A1 |
| Guy Champagne | Director | Fanny Bay, A1 |
| Dawn Wattie | Executive Officer | White Rock, A1 |
Other filings by this issuer (3)
More